Cargando…

Immunological perspective on the malignant progression of renal clear cell carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common malignancy affecting the kidneys, accounting for approximately 75% of all kidney tumors. Recently, the impact of immune response, immunotherapy, and immune-related genes (IRGs) on tumor development has received much attention. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ji, Zhang, Wentao, Lin, Kang, Ma, Wenchao, Li, Wei, Yao, Xudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576724/ https://www.ncbi.nlm.nih.gov/pubmed/34790750 http://dx.doi.org/10.21037/atm-21-4973

Ejemplares similares

N(6)-methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma
por: Zheng, Zongtai, et al.
Publicado: (2020)

Dysregulation of tumor microenvironment promotes malignant progression and predicts risk of metastasis in bladder cancer
por: Liu, Ji, et al.
Publicado: (2021)

FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma
por: Lv, Zheng, et al.
Publicado: (2021)

Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma
por: Liu, An, et al.
Publicado: (2022)

FBXL6 depletion restrains clear cell renal cell carcinoma progression
por: Yu, Yongchun, et al.
Publicado: (2022)

Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment
por: Wei, Xiyi, et al.
Publicado: (2021)

Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma
por: Zhang, Shiqiang, et al.
Publicado: (2021)

Features of increased malignancy in eosinophilic clear cell renal cell carcinoma
por: Nilsson, Helén, et al.
Publicado: (2020)

A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma
por: Chen, Ji, et al.
Publicado: (2023)

Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma
por: Liu, Yifu, et al.
Publicado: (2023)

Identification of neoantigens and immunological subtypes in clear cell renal cell carcinoma for mRNA vaccine development and patient selection
por: Zhu, Daoqi, et al.
Publicado: (2023)

GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression
por: Wu, Xiao-rong, et al.
Publicado: (2016)

Leptin Is Associated with Poor Clinical Outcomes and Promotes Clear Cell Renal Cell Carcinoma Progression
por: Fan, Wen-Lang, et al.
Publicado: (2021)

Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma
por: Zhu, Maoshu, et al.
Publicado: (2023)

Effect of m(6)A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma
por: Wang, Jiawu, et al.
Publicado: (2020)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

Effect of Aberrant Long Noncoding RNA on the Prognosis of Clear Cell Renal Cell Carcinoma
por: Wu, Han, et al.
Publicado: (2021)

The prognostic value and immunological role of the small mother against decapentaplegic proteins in kidney renal clear cell carcinoma
por: Zhang, Siyue, et al.
Publicado: (2021)

Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α
por: Fan, Yang, et al.
Publicado: (2016)

The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma
por: Chu, Binxiang, et al.
Publicado: (2022)

Recent Trends in the Incidence of Clear Cell Adenocarcinoma and Survival Outcomes: A SEER Analysis
por: Guo, Yadong, et al.
Publicado: (2022)

Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma
por: Chiu, I-Jen, et al.
Publicado: (2020)

Clinical Implications of HSC70 Expression in Clear Cell Renal Cell Carcinoma
por: Zhang, Yixiao, et al.
Publicado: (2021)

PPARγ is dispensable for clear cell renal cell carcinoma progression
por: Sanchez, Danielle J., et al.
Publicado: (2018)

A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma
por: Gao, Jiahao, et al.
Publicado: (2022)

Metastatic renal clear-cell carcinoma to the gallbladder: A radiologist’s perspective
por: Bolus, Christopher C., et al.
Publicado: (2015)

Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapy
por: Chen, Can, et al.
Publicado: (2023)

Notch 1 is a valuable therapeutic target against cell survival and proliferation in clear cell renal cell carcinoma
por: Zhuang, Zhiming, et al.
Publicado: (2017)

Paraneoplastic Eosinophilia in Clear Cell Renal Cell Carcinoma
por: Zhou, Wei-Wei, et al.
Publicado: (2015)

Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
por: Liu, Xuehe, et al.
Publicado: (2023)

Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer
por: Zheng, Zongtai, et al.
Publicado: (2020)

Glycogen metabolism is dispensable for tumor progression in clear cell renal cell carcinoma
por: Xie, Hong, et al.
Publicado: (2021)

LncRNAs Expression Signatures of Renal Clear Cell Carcinoma Revealed by Microarray
por: Yu, Gan, et al.
Publicado: (2012)

RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma
por: Chen, Weihao, et al.
Publicado: (2016)

Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma
por: Wu, Zonglong, et al.
Publicado: (2022)

OGT/HIF-2α axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis
por: Yang, Zhou, et al.
Publicado: (2023)

Overexpression of CKAP4 is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma and Functions via Cyclin B Signaling
por: Sun, Chen-min, et al.
Publicado: (2017)

Comprehensive analysis of the importance of PLAUR in the progression and immune microenvironment of renal clear cell carcinoma
por: Wang, Zhiwei, et al.
Publicado: (2022)

Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles
por: Govindarajan, Ameish, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pjkg0i7kah4ocmk87f4tv7fvcd